Transcripts

ProMIS Neurosciences (PMN) earnings call transcripts

Earnings call transcripts for ProMIS Neurosciences Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the blinded interim results as initial human support for PMN 310’s oligomer-selective thesis, while stressing that efficacy remains unproven.

    Aug 13, 2026Confident0.72